Contains phenylalanine, soya beans and sulfites
Formulated with a liposomal delivery system for optimal absorption
This system detected the association between GLP-1 medications and thyroid tumors in animal studies, leading to boxed warnings on approved products
A multicenter, double-blind RCT assessed the efficacy and safety of ALC in diabetic peripheral neuropathy compared with methylcobalamin
resolve with titration.[1][43] Absolute Contraindications : History of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2.[3][44] Relative Contraindications : Pancreatitis, severe GI disease, pregnancy/breastfeeding.[1][45] Monitoring Parameters : HbA1c, lipids, liver enzymes, renal function every 3 months.[4][46] Regulatory Status FDA Classification : Investigational (Phase 3)
These analyses were carried out in two separate groups of rats